A virtual Egg-Carrying game may reveal how well children control their hands

NCT ID NCT07793032

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

Researchers are testing a device called the Virtual Eggs Test (VET) to see if it can measure hand dexterity in children and young adults with cerebral palsy or developmental coordination disorder. The test involves carrying fragile objects across a platform without breaking them, which requires careful grip control. The study will compare results from these participants with those from typically developing children to establish normal values. If the test proves valid, it could offer a new way for therapists to assess and monitor hand skills.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual Eggs Test (VET), a device that measures hand dexterity by having participants carry fragile objects without breaking them
What this could lead to
If it works, the Virtual Eggs Test could become a reliable tool for measuring hand skills in children with cerebral palsy or coordination difficulties, helping therapists track progress and plan care.
What could go wrong
This is an early validation study, not a treatment trial. The test may not prove accurate or practical in real-world clinics, and results from this specific group may not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 130 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 21 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Inclusion Criteria - Cerebral Palsy Group * Diagnosis of Cerebral Palsy; * Participants of either sex and of any ethnicity, aged between 6 and 21 years at the time of recruitment; * MACS Level I-III (for participants with Cerebral Palsy); * BFMF Level I-IV (for participants with Cerebral Palsy); * House Functional Classification Level 4-8; * At least one cognitive index score \>70 on the WISC-IV, WISC-V, or WAIS-IV; * Participants who have provided informed consent, or for whom the legal guardian has provided informed consent and acknowledged receipt of the study information sheet. Inclusion Criteria - Developmental Coordination Disorder Group * Diagnosis of Developmental Coordination Disorder; * Participants of either sex and of any ethnicity, aged between 6 and 21 years at the time of recruitment; * Total mABC-2 score below the 15th percentile; * At least one cognitive functioning index score not lower than 2 standard deviations below the population mean, assessed using standardized tests performed within the previous 12 months, in order to ensure sufficient ability to understand and cooperate with the proposed activities; * Participants who have provided informed consent, or for whom the legal guardian has provided informed consent and acknowledged receipt of the study information sheet. Inclusion Criteria - Control Group * Participants of either sex and of any ethnicity, aged between 6 and 21 years; * Green zone on the mABC-2 Checklist; * Participants with cognitive and language abilities adequate to understand the experiment and follow instructions; * Participants who have provided informed consent, or for whom the legal guardian has provided informed consent and acknowledged receipt of the study information sheet. Exclusion Criteria: Exclusion Criteria - Cerebral Palsy and Developmental Coordination Disorder Groups * Participants with evident visual or oculomotor impairments; * Concomitant general or localized comorbidities/disabilities (e.g., multiple sclerosis, Parkinson's disease, muscle tone disorders, malignant neoplasms, etc.) that may interfere with the ability to understand and perform the study protocol; * Presence of pathological cardiopulmonary or cardiovascular conditions; * Pregnancy or breastfeeding; * Insufficient level of cooperation. Exclusion Criteria - Control Group * Participants with evident visual or oculomotor impairments; * Concomitant general or localized comorbidities/disabilities (e.g., multiple sclerosis, Parkinson's disease, muscle tone disorders, malignant neoplasms, etc.) that may interfere with the ability to understand and perform the study protocol; * Presence of pathological cardiopulmonary or cardiovascular conditions; * Pregnancy or breastfeeding; * Presence of psychiatric comorbidities; * Insufficient level of cooperation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy (CP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • IRCCS Fondazione Stella Maris

    Calambrone, Pisa, 56128, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.